skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: As a new subscriber, Iím thoroughly impressed with your advice and 5i Research services overall - thank you for all that you do.

I currently hold ABBV, BMY, CVS, and GSK in a long-term hold, diversified RRSP portfolio. Iím not necessarily looking to add further healthcare exposure, but am very interested in the long term prospects for MRK +/- ISRG and would appreciate your opinion on them. And compared to my existing companies, would there be a suggested ranking of these six in terms of potential for long term compounding growth?

Read Answer Asked by Anthony on October 12, 2021

Q: I own Abbvie already and would like to add another company from the health care sector. What would be your next choice for a long term hold in a dividend focused portfolio? Considering maybe JNJ, PFE, BMY, AMGN, ABT, MRK.

Read Answer Asked by Serei on September 29, 2021

Q: i have held this for about 5 years and it has basically done nothing despite all the promises from management for change/consolidation etc. Would you support continuing to hold or am i better switching to a better growth name. i am retired so i like a bit of income in addition to share price appreciation. i already own ABBV and MDT and do not want to add to these positions. i am better off in Merck or PFE?

Read Answer Asked by kelly on April 07, 2021

Q: I am looking to add 1 or 2 U. S. Healthcare companies to my U. S. cash account. Of the 4 above could you list them in order from best to worst with a comment on thier financial and growth situation. Please include any other choices that you might add to my list.
Much appreciated.
John

Read Answer Asked by John on March 23, 2021

Q: Hi 5i,
Current shareholder of BMY for last 4 years and it simply has not done very much however pays small dividend of 3.2 %
I'm looking to sell and replace with something in same sector/space with better share price growth potential. Medium risk with 2- 3 year horizon. Dividend would be nice but not absolutely necessary.
Thx
Jim

Read Answer Asked by jim on March 10, 2021

Q: In the healthcare sector I hold ABBV, BMY, MDT, AZN and CVS. Am looking to swap one out for a growth/value holding, perhaps in Industrials (maybe LMT?). Was thinking AZN would be my odd one out. Would appreciate your thoughts on best approach for long term buy and hold portfolio given the 5 holdings noted here. Thanks.

Read Answer Asked by Jody on February 17, 2021

Q: Can I get your thoughts on the valuation of the healthcare industry? Could you provide a few picks on dividend paying healthcare stocks?

Thanks,

Joe

Read Answer Asked by Joe on October 20, 2020

Q: Hi there. I hold positions in ABBV, PFE, MRNA, and AMGEN. I am looking for some supplemental help in the healthcare space and considering MDT, WBA, JNJ(on pull back and aware of legal risks).

What would your opinion and/or recommendations be on these companies JNJ/WBA/MDT Do you have one or two alternatives for a dividend conscious investor?

Thank you so much.
Peter

Read Answer Asked by Peter on October 19, 2020

Q: I currently have PFE, GILD, MDT and ABBV in my Healthcare sector. I am looking to add a couple of names - I have been looking at MRK and BMY - your opinion please on these AND can you provide some other US healthcare companies that might be of interest to you at this time. Greatly appreciate your comments.
Thanks

Read Answer Asked by JOHN on October 06, 2020

Q: Hi Guys,
I would like your expert opinion on the following stocks, VOYA, BMY, GM and EQH. My portfolio contains a combination of growth and income stocks. Would you consider the aforementioned to be buys, holds or sells?

Read Answer Asked by Bob on August 31, 2020

Q: Dear Sirs,
What do you think of BMY at this time? Do you think it's too early to be buying these guys? I don't see anything they're doing regarding coronavirus treatment, so they may keep falling for awhile. They've done some good stuff recently: acquired Celgene (cancer) and Medarex (cancer) and have a leading drug partnered with Pfizer (prevention of blood clots caused by atrial fibrillation). They're down to about $49 from about $65 a month ago (like everyone). Thank you.

Read Answer Asked by Allan on March 20, 2020

Q: With the world feeling a little uneasy about a pending recession, I want to keep only holdings that will weather a downturn. I'm not trying to time the market, and want to hold stocks, that while they may dip, have good balance sheets, good management, and will likely see a recovery. Others I will sell and hold the cash. Above are my current holdings. Do you see any that may be susceptible to excessive weakness in a recession and would therefore meet my sell criterion? Thanks,
Kim

Read Answer Asked by Kim on August 27, 2019